OncBioMune Pharmaceuticals Inc. appointed Brian Barnett to replace Jonathan Head as CEO of the company, effective Dec. 26.
Head will continue to serve as OncBioMune's board chairman and was appointed chief scientific officer.
Before joining OncBioMune, Barnett had served at Puma Biotechnology Inc. as vice president and head of medical affairs since August 2016.
Baton Rouge, La.-based OncBioMune Pharmaceuticals is a clinical-stage biopharmaceutical company that develops cancer immunotherapy products.